RecruitingNCT06572215

DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve


Sponsor

King's College Hospital NHS Trust

Enrollment

44 participants

Start Date

Dec 14, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This is a feasibility study to assess new, more practical ways of measuring renal reserve.


Eligibility

Min Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This study is testing new ways to measure how well the kidneys can handle extra work — called kidney functional reserve. It focuses on people with sickle cell disease who have kidney involvement, as well as people who have previously donated a kidney. **You may be eligible if...** - You have sickle cell disease with kidney involvement (sickle cell nephropathy) - OR you have previously donated a kidney as a living donor - You are 40 years of age or older - You have no known allergies to the medications used in the study - You are able to give written informed consent **You may NOT be eligible if...** - You are under 40 years old - You are pregnant or breastfeeding - You are currently enrolled in another interventional study - You are unable or unwilling to provide consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGDapagliflozin

On Day 3 to 16, participants will take 10mg dapaglifozin (SGLT-2 inhibitor) orally once daily.


Locations(1)

King's College Hospital

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06572215


Related Trials